Alyeska Investment Group
DRNA

Alyeska Investment Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Alyeska Investment Group’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-68,406
Closed -$871K – 551
2014
Q3 		$871K Buy
+68,406
New +$1.03M 0.02% 336
2014
Q2 		– Sell
-50,000
Closed -$1.41M – 477
2014
Q1 		$1.41M Buy
+50,000
New +$1.86M 0.04% 278

Other funds holding DRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group's DRNA Position: Q4 2014 in Review

Alyeska Investment Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2014, closing a stake of 68,406 shares — an estimated $871K sold.

Alyeska Investment Group first reported a position in DRNA in Q1 2014 and held it in 2 quarters. The position peaked at $1.41M in Q1 2014. 47 funds tracked by Wall St. Rank hold DRNA as of Q4 2014.

  • Alyeska Investment Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Alyeska Investment Group sold 68,406 Dicerna Pharmaceuticals, Inc. shares in Q4 2014, an estimated $871K.
  • Alyeska Investment Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
  • Alyeska Investment Group's Dicerna Pharmaceuticals, Inc. position peaked at $1.41M in Q1 2014.
  • 47 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2014.

Based on Alyeska Investment Group's 13F filing for Q4 2014, filed 17 Feb 2015.